These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16239022)

  • 1. The interference of botanicals and nutraceuticals with the effects of antithrombotic agents: how should the available evidence be weighed?
    De Smet PA
    Thromb Res; 2005; 117(1-2):19-24; discussion 39-42. PubMed ID: 16239022
    [No Abstract]   [Full Text] [Related]  

  • 2. The interaction of dietary supplements with antithrombotic agents: scope of the problem.
    Marder VJ
    Thromb Res; 2005; 117(1-2):7-13; discussion 39-42. PubMed ID: 16076481
    [No Abstract]   [Full Text] [Related]  

  • 3. Remarks on clinical data concerning dietary supplements that affect antithrombotic therapy.
    Lichtenstein AH
    Thromb Res; 2005; 117(1-2):71-3; discussion 113-5. PubMed ID: 15951007
    [No Abstract]   [Full Text] [Related]  

  • 4. The rational use of dietary supplements and nutraceuticals in clinical medicine.
    Mechanick JI
    Mt Sinai J Med; 2005 May; 72(3):161-5. PubMed ID: 15915310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dietary supplements on aspirin and other antiplatelet agents: an evidence-based approach.
    Desai D; Hasan A; Wesley R; Sunderland E; Pucino F; Csako G
    Thromb Res; 2005; 117(1-2):87-101; discussion 113-5. PubMed ID: 16115664
    [No Abstract]   [Full Text] [Related]  

  • 6. Nutraceuticals: miracle or meme?
    Ridinger MH
    Clin Pharmacol Ther; 2007 Oct; 82(4):352-6. PubMed ID: 17851571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergism, antagonism, or additivity of dietary supplements: application of theory to case studies.
    Borgert CJ; Borgert SA; Findley KC
    Thromb Res; 2005; 117(1-2):123-32; discussion 145-51. PubMed ID: 16023178
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of botanicals in food supplements. Regulatory scope, scientific risk assessment and claim substantiation. 2005.
    Coppens P; Delmulle L; Gulati O; Richardson D; Ruthsatz M; Sievers H; Sidani S;
    Ann Nutr Metab; 2006; 50(6):538-54. PubMed ID: 17191027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comments on public health concerns: facts, fiction, and gaps in knowledge.
    Hoffman FA
    Thromb Res; 2005; 117(1-2):177-8; discussion 201-7. PubMed ID: 16183104
    [No Abstract]   [Full Text] [Related]  

  • 10. Comments on public health concerns: facts, fiction and gaps in knowledge.
    Hoffman FA
    Thromb Res; 2005; 117(1-2):177-84; discussion 201-7. PubMed ID: 16182345
    [No Abstract]   [Full Text] [Related]  

  • 11. Challenges in collecting, accessing and evaluating post market surveillance AERS in patients receiving dietary supplements.
    Kingston R
    Thromb Res; 2005; 117(1-2):137-44; discussion 145-51. PubMed ID: 16139875
    [No Abstract]   [Full Text] [Related]  

  • 12. Criteria for risk assessment of botanical food supplements.
    Walker R
    Toxicol Lett; 2004 Apr; 149(1-3):187-95. PubMed ID: 15093264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Legislation relating to nutraceuticals in the European Union with a particular focus on botanical-sourced products.
    Gulati OP; Berry Ottaway P
    Toxicology; 2006 Apr; 221(1):75-87. PubMed ID: 16487647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance and problems of special foods for health claim].
    Itakura H; Terada S
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():244-9. PubMed ID: 12387000
    [No Abstract]   [Full Text] [Related]  

  • 15. Herbal history.
    Parolia A
    Br Dent J; 2010 Oct; 209(8):368. PubMed ID: 20966981
    [No Abstract]   [Full Text] [Related]  

  • 16. Readers' and author's responses to "Evidence-based standards should apply to dietary supplements, too".
    Driscoll HB
    MedGenMed; 2007; 9(4):21; author reply 21. PubMed ID: 18320626
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment of nutraceuticals and food supplements.
    Belcaro G; Cornelli U; Ledda A; Hosoi M
    Panminerva Med; 2011 Sep; 53(3 Suppl 1):I-II. PubMed ID: 22108488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The quality of commercially available nutraceutical supplements and food sources.
    Lockwood GB
    J Pharm Pharmacol; 2011 Jan; 63(1):3-10. PubMed ID: 21155809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European regulations on nutraceuticals, dietary supplements and functional foods: a framework based on safety.
    Coppens P; da Silva MF; Pettman S
    Toxicology; 2006 Apr; 221(1):59-74. PubMed ID: 16469424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to evaluate the safety, efficacy, and quality of functional foods and their ingredients.
    Hasler C; Moag-Stahlberg A; Webb D; Hudnall M
    J Am Diet Assoc; 2001 Jul; 101(7):733-6. PubMed ID: 11478464
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.